Pharmaceutical - Financial, Actavis

Filter

Current filters:

FinancialActavis

Popular Filters

AstraZeneca acquires rights to Actavis’ branded respiratory portfolio in USA and Canada

AstraZeneca acquires rights to Actavis’ branded respiratory portfolio in USA and Canada

05-02-2015

Anglo-Swedish pharma major AstraZeneca has acquired the rights to Ireland-headquartered generics major…

ActavisAstraZenecaDalirespFinancialPharmaceuticalRespiratory and PulmonaryTudorza PressairUSA

Actavis reports 2nd-qtr revenues increase by over a third

Actavis reports 2nd-qtr revenues increase by over a third

05-08-2014

Ireland-headquartered generics major Actavis has reported a 34% boost in revenue in the second quarter…

ActavisActavis PharmaBusiness FinanceBusiness FinanceFinancialIrelandPharmaceutical

Fitch affirms Actavis at “BBB-” on Forest Labs acquisition; outlook Stable

20-02-2014

Fitch Ratings has affirmed the ratings of generic drugs major Actavis and subsidiaries at “BBB-”…

ActavisFinancialForest LaboratoriesMergers & AcquisitionsPharmaceutical

EU Commission fines Lundbeck and other Pharmas over "pay-for-delay" deals

19-06-2013

In a much awaited decision following its investigations of patent settlements (or pay-for-delay deals)…

ActaviscitalopramEuropeFinancialGenericsLegalLundbeckMerck KGaAMylan LaboratoriesNeurologicalPatentsPharmaceuticalRanbaxy Laboratories

Actavis and Warner Chilcott leap on merger talks; possible bid for Adcock Ingram

13-05-2013

US generics major Actavis NYSE: ACT) confirmed on Friday (May 10) that it has entered into early stage…

ActavisAdcock IngramFinancialGenericsMergers & AcquisitionsPharmaceuticalWarner Chilcott

QRxPharma value assed as Actavis deal finalized

29-03-2012

Australian company QRxPharma (ASX: QRX) is moving rapidly towards the commercial phase for its lead product,…

ActavisFinancialLicensingNeurologicalPharmaceuticalQRxPharmaRegulation

COMPANY SPOTLIGHT

Menarini

Back to top